McCulloch Kevin Insider Trading -- Recent SEC Form 4 Transactions
McCulloch Kevin (CIK 2031695) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-02). Recent activity: Sell XERS (15,000 shares), Sell XERS (25,000 shares), Sell XERS (15,000 shares), Sell XERS (21,918 shares), Sell XERS (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 15,000 | $141,120 |
| 2026-09-29 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 25,000 | $250,000 |
| 2026-09-01 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 15,000 | $127,308 |
| 2026-08-21 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 21,918 | $177,097 |
| 2026-08-04 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 15,000 | $120,240 |
| 2026-07-02 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 90,000 | $722,511 |
| 2026-03-16 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Buy | 48,894 | $199,976 |
| 2026-03-16 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Buy | 4 | $16 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Buy | 168,463 | $0 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 68,454 | $503,821 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 30,289 | $222,927 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 27,319 | $201,068 |
| 2026-01-09 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 15,000 | $120,000 |
| 2025-10-03 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 733 | $6,091 |
| 2025-09-15 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 2,000 | $0 |
| 2025-08-04 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Sell | 14,651 | $78,822 |
| 2025-06-16 | Xeris Biopharma Holdings, Inc. (XERS) | President and Chief Operating Officer | Buy | 25,000 | $109,500 |
Source: SEC Form 4 filings · as of 2026-10-02